Here are Wednesday's biggest analyst calls: Nvidia, Tesla, Dell, First Solar, Affirm, Teva, Robinhood & more

Wall Street's Wednesday calls were broadly bullish, featuring upgrades and Buy/Outperform initiations across biotech, fintech, AI, energy, infrastructure and consumer companies. Notable upside cases included JPMorgan's $6 Lithium Americas target implying 100% upside, StoneX's $75 Aptiv target implying about 64% upside, and Evercore ISI raising Dell's target to $650 from $575 while citing potential upside to $1,000. Other positive calls included Buy initiations on Affirm ($105 target), Robinhood ($170), Quanta Services ($731), First Solar ($260), AstraZeneca, Teva and Bausch + Lomb, while Wells Fargo maintained an Underweight rating on Tesla despite August deliveries trending up 45% month over month but down 4% year over year.

Analysis

This is a broad initiation/upgrade tape rather than a discrete fundamental catalyst, so the highest-probability effect is short-lived retail and quant flow into the smaller, less-liquid names. FTH, SGMT, AKTS, KDK and PSQL-type development-stage stories are especially vulnerable to a gap-and-fade pattern because target prices do not alter trial timelines, cash burn, dilution needs, or commercialization risk. Avoid chasing first-day strength absent confirmation from unusual volume, borrow availability and a near-term company-specific milestone.

The more investable common factor is a renewed preference for operationally leveraged infrastructure and platforms: PWR, DELL and APTV can convert sustained utility-grid, enterprise-AI and vehicle-content spending into earnings revisions, unlike pre-revenue technology proxies. PWR is the cleanest expression because backlog conversion and labor scarcity can support pricing, but its premium multiple leaves downside if transmission permitting or utility capital budgets slip. DELL's upside requires AI-server attach and mix improvement to materialize in reported gross margin; headline AI order growth without margin expansion would be insufficient.

Fintech bullishness across AFRM, HOOD, CHYM and DAVE is directionally supportive but masks materially different credit exposure. AFRM and DAVE are most exposed to consumer delinquency and funding-cost surprises, while HOOD is more directly geared to retail trading, crypto volumes and net-interest income; a risk-on tape can lift all four initially, but a weaker labor or consumer-credit print should create sharp dispersion. The contrarian setup is TSLA: improving sequential delivery checks are seasonal and do not resolve annual volume, pricing, or auto-gross-margin risk, leaving rallies on monthly datapoints more suitable for sale than a durable long.

Over 6-18 months, LAC and FSLR express opposite sides of policy-sensitive energy-transition capital spending. LAC's valuation can re-rate only if lithium pricing stabilizes and financing/execution risk falls; FSLR's contracted economics provide more visible downside protection, although policy changes affecting domestic-content incentives remain the key multiple risk. Analyst enthusiasm alone should not be treated as validation of either terminal-value assumption.

Key Decisions for Investors

• Initiate a 1-3 month long PWR / short XLI pair on pullbacks, targeting relative upside from backlog and grid-capex earnings revisions; exit if PWR's next guidance implies backlog growth below mid-single digits or utility capex plans are cut. This isolates electrical-infrastructure spending from broader industrial cyclicality.
• Buy DELL only after its next results confirm AI-server revenue growth alongside gross-margin stability or improvement; use a 7-10% stop versus entry. The risk/reward is favorable only if higher-margin storage, networking and services attach offsets low-margin server mix.
• Avoid or tactically short strength in the small-cap biotech initiation basket (FTH, SGMT, AKTS) after a >15% one-day move without independently verifiable clinical, regulatory, or financing news. Cover ahead of disclosed clinical readouts; borrow cost and liquidity are gating data before implementation.
• Express fintech dispersion over the next 1-3 months: long HOOD versus short AFRM in equal beta-adjusted dollars. HOOD has stronger exposure to trading/crypto activity, while AFRM bears greater credit and funding sensitivity; close if consumer delinquencies remain benign while AFRM raises full-year credit guidance.
• Maintain TSLA underweight and sell rallies tied to monthly delivery commentary; reassess only if quarterly deliveries recover year-over-year while automotive gross margin excluding credits stabilizes. A broad China price increase or credible low-cost-model production ramp would falsify the short thesis.